Evidence map›Paper›PMID 34622559›Full record

ArticleCancer medicine2021

Lymph node metastases >5 and metastatic lymph node ratio >0.30 of differentiated thyroid cancer predict response to radioactive iodine.

Canhua Yun, Juan Xiao, Jingjia Cao, Chunchun Shao, Lihua Wang, Wei Zhang, Hongying Jia

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Predicting excellent response to radioiodine in differentiated thyroid cancer using machine learning.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2024
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Canhua YunDepartment of Nuclear Medicine, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Juan XiaoCenter of Evidence-Based Medicine, The Second Hospital, Cheeloo College of Medicine, Institute of Medical Sciences, Shandong University, Jinan, China.
Jingjia CaoDepartment of Nuclear Medicine, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Chunchun ShaoCenter of Evidence-Based Medicine, The Second Hospital, Cheeloo College of Medicine, Institute of Medical Sciences, Shandong University, Jinan, China.
Lihua WangSchool of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China.
Wei ZhangDepartment of Nuclear Medicine, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Hongying JiaCenter of Evidence-Based Medicine, The Second Hospital, Cheeloo College of Medicine, Institute of Medical Sciences, Shandong University, Jinan, China.ORCID 0000-0001-8079-1161
Second Hospital of Shandong University · CNShandong University · CN

Funding

Jinan Science and Technology Innovation Development Plan 202019194the Youth Fund of the Second Hospital of Shandong University 2018YT42
6 · The paper itself

Abstract

purposeThe study was designed to elucidate the predictive value of the number of lymph node metastases (LNMs) and lymph node ratio (LNR) for response to therapy restratification system (RTRS).

methodsFrom December 2015 to December 2019, 1228 patients who accepted radioactive iodine (RAI) were collected in the study. After 6-8 months, response to RAI was evaluated as complete response (excellent response) and incomplete response (indeterminate, biochemical, and structural incomplete response). The study developed classification tree to determine the optimum LNMs and LNR that predicted response to RAI. Multivariate logistic regression analyses were further analyzed to find independent factors of response to RAI.

resultThe mean age of patients was 44 ± 12 and 71.09% (873/1228) were females. The best cutoff value of LNMs to affect RAI treatment response determined by classification tree was 5. Further in 388 patients with LNMs >5, the best cutoff value of LNR to affect RAI treatment response determined by classification tree was 0.30. With multivariate analysis, the study found that LNMs (>5), gender, lymph node dissection, and American Thyroid Association (ATA) risk classification were independent predictors of response to RAI for all 1228 patients; and LNR (>0.30), gender, and ATA risk classification for 388 patients with LNMs >5. The sensitivity analysis indicated that whether patients with LNM or not were included, the multivariate logistic regression model was kept stable. On subgroup analysis, no significant interactions were observed between the effect of LNMs/LNR and gender, N stage, ATA risk classification, lymph node dissection, or T stage.

conclusionsWith classification tree, the study found that LNMs and LNR could predict initial response to RAI, and their optimal cutoff values were 5 and 0.30, separately.

Indexed as

Lymphatic MetastasisLymph Node RatioAdultFemaleHumansIodine RadioisotopesMaleMiddle AgedRegression AnalysisRisk AssessmentThyroid NeoplasmsTreatment OutcomeIodine Radioisotopesclassification treedifferentiated thyroid cancerLNMsLNRradioactive iodine

Identifiers

PMID34622559
PMCPMC8559488
OpenAlexW3209909257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.